Full name: family with sequence similarity 47 member C | Alias Symbol: | ||
Type: protein-coding gene | Cytoband: Xp21.1 | ||
Entrez ID: 442444 | HGNC ID: HGNC:25301 | Ensembl Gene: ENSG00000198173 | OMIM ID: |
Drug and gene relationship at DGIdb |
Expression of FAM47C:
Dataset | Gene | EntrezID | Probe | Log2FC | Adj.pValue | Expression |
---|---|---|---|---|---|---|
GSE17351 | FAM47C | 442444 | 239732_x_at | -0.0035 | 0.9883 | |
GSE26886 | FAM47C | 442444 | 239732_x_at | -0.0164 | 0.8874 | |
GSE45670 | FAM47C | 442444 | 239732_x_at | 0.0927 | 0.1649 | |
GSE53622 | FAM47C | 442444 | 111619 | -0.0092 | 0.9580 | |
GSE53624 | FAM47C | 442444 | 111619 | 0.2031 | 0.0673 | |
GSE63941 | FAM47C | 442444 | 239732_x_at | 0.0975 | 0.4664 | |
GSE77861 | FAM47C | 442444 | 239732_x_at | -0.1276 | 0.2215 |
Upregulated datasets: 0; Downregulated datasets: 0.
Survival by FAM47C expression:
Note: Click image to view full size file.
Copy number change of FAM47C:
No record found for this gene.
Somatic mutations of FAM47C:
Generating mutation plots.
Highly correlated genes for FAM47C:
Showing top 20/32 corelated genes with mean PCC>0.5.
Gene1 | Gene2 | Mean PCC | Num. Datasets | Num. PCC<0 | Num. PCC>0.5 |
---|---|---|---|---|---|
FAM47C | ARHGEF25 | 0.700662 | 3 | 0 | 3 |
FAM47C | TRIM10 | 0.662068 | 3 | 0 | 3 |
FAM47C | PNLIP | 0.661434 | 3 | 0 | 3 |
FAM47C | GDAP1L1 | 0.635968 | 3 | 0 | 3 |
FAM47C | CASR | 0.623819 | 3 | 0 | 3 |
FAM47C | SYT6 | 0.618959 | 3 | 0 | 3 |
FAM47C | RUSC2 | 0.614531 | 3 | 0 | 3 |
FAM47C | KCNN3 | 0.611518 | 3 | 0 | 3 |
FAM47C | FAM47B | 0.599269 | 3 | 0 | 3 |
FAM47C | FOXD2-AS1 | 0.591752 | 3 | 0 | 3 |
FAM47C | CLYBL-AS1 | 0.581101 | 3 | 0 | 3 |
FAM47C | FAM216B | 0.574218 | 3 | 0 | 3 |
FAM47C | SCN4A | 0.573384 | 3 | 0 | 3 |
FAM47C | ADAMTS19 | 0.569052 | 3 | 0 | 3 |
FAM47C | COX6A2 | 0.568631 | 3 | 0 | 3 |
FAM47C | ISLR2 | 0.567005 | 3 | 0 | 3 |
FAM47C | IL2 | 0.559716 | 3 | 0 | 3 |
FAM47C | HHIP-AS1 | 0.556814 | 4 | 0 | 3 |
FAM47C | NPR1 | 0.556026 | 4 | 0 | 3 |
FAM47C | RASL10B | 0.553013 | 4 | 0 | 3 |
For details and further investigation, click here